| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 27 |
| 1 | PREDNISONE | 16 |
| 2 | FOLIC ACID | 14 |
| 3 | FUROSEMIDE | 12 |
| 4 | HUMAN IMMUNOGLOBULIN G | 12 |
| 5 | DARBEPOETIN ALFA | 11 |
| 6 | OMEPRAZOLE MAGNESIUM | 10 |
| 7 | FLUDARABINE PHOSPHATE | 9 |
| 8 | OMEPRAZOLE | 9 |
| 9 | SIMVASTATIN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOTETAN DISODIUM | 2 | 0.0179 |
| 1 | CEFOTETAN | 2 | 0.0150 |
| 2 | FLOXURIDINE | 1 | 0.0058 |
| 3 | GLYBURIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0046 |
| 4 | IPTACOPAN | 2 | 0.0025 |
| 5 | APOMORPHINE HYDROCHLORIDE | 4 | 0.0024 |
| 6 | HUMAN RHO(D) IMMUNE GLOBULIN | 2 | 0.0019 |
| 7 | TAGRAXOFUSP | 1 | 0.0019 |
| 8 | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | 1 | 0.0014 |
| 9 | DINUTUXIMAB | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 29 |
| 1 | Corticosteroid [EPC] | 24 |
| 2 | Human Immunoglobulin G [EPC] | 20 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 4 | Vitamin C [EPC] | 17 |
| 5 | Vitamin B12 [EPC] | 16 |
| 6 | Platinum-based Drug [EPC] | 15 |
| 7 | Vitamin D [EPC] | 15 |
| 8 | Loop Diuretic [EPC] | 14 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 2 | Human Immunoglobulin G [EPC] | 20 | 0.0009 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 4 | Complement Inhibitor [EPC] | 29 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 7 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 8 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 9 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |